Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Scientists restructure the genome of E. coli using fragments extracted from mummy

An international group led by McMaster University researchers, in partnership with the University of Paris Cité, has recognized and reconfigured the first ancient genome of E. coli using fragments derived from a 16th-century mummy’s gallstone.

17 Jun 2022

Novel insights into how some bacteria evade antibiotics

Scientists have revealed how antibiotics can regress certain fast-growing bacteria. The research was published in the journal eLife on June 8th, 2022.

8 Jun 2022

Research findings provide clues on the properties that might have made A. baumannii a successful pathogen

Over 670,000 people in Europe become ill each year as a result of pathogenic bacteria that are resistant to antibiotics, and 33,000 people die as a result of the diseases they cause. Pathogens that are resistant to multiple antibiotics at the same time are particularly dangerous.

6 Jun 2022

Researchers discover distinctive antibacterial therapy that uses visible light-activated synthetic molecular machine

Infectious-bacteria-killing molecular machines have been persuaded to reconsider their goal.

2 Jun 2022

Study discovers new antibiotics effective against drug-resistant tuberculosis

Every year, 1.5 million people die from infections caused by Mycobacterium tuberculosis. Antibiotics are available to treat tuberculosis, but the bacteria has evolved multi-drug resistant (MDR), extensively drug-resistant (XDR), and fully drug-resistant (TDR) strains in recent years.

1 Jun 2022

Research shows how current drugs impact bacterial physiology

Tuberculosis is a stubborn disease caused by even more stubborn bacteria. While many bacterial infections clear up within days of taking antibiotics, TB can take up to six months to clear up and, in some cases, never leave the human body. In 2020, it claimed 1.5 million lives, second only to COVID-19 in terms of infectious disease deaths.

1 Jun 2022

Damaged liver treated in perfusion machine for three days and then implanted into a cancer patient

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient.

1 Jun 2022

Type I interferon may activate a potent immune response against harmful viruses

Researchers at McMaster University have discovered not only how specific viral infections potentially cause tissue damage, but also how to prevent it.

23 May 2022

Immune-boosting drugs with antibiotics may reduce the health risks of fungal infections

Patients are more susceptible to fungal infections because the immune system in the gut is disrupted when patients are given antibiotics in the hospital.

18 May 2022

Scientists detect rare genetic signs of drug-resistant tuberculosis with the aim to stop disease progression

Many people believe tuberculosis (TB) is a disease of the past. Nonetheless, it claims over a million lives each year. Furthermore, the problem is escalating as Mycobacterium tuberculosis—the pathogen that causes tuberculosis develops resistance to the antibiotics used to treat the disease.

12 May 2022

Researchers highlight a phage-antibiotic combo against antibiotic-resistant superbug

A preclinical study performed by Monash University researchers discovered that utilizing a combination of phages and antibiotics to treat bacterial infections may be considerably more successful than using the drugs separately.

12 May 2022

Study addresses genetic diversity of Clostridioides difficile using systems biology technique

Researchers from Jacobs School of Engineering and the University of California San Diego School of Medicine collaborated with colleagues from Baylor College of Medicine to decode the genetic diversity of Clostridioides difficile, an especially dangerous pathogen in healthcare settings, using a systems biology technique.

29 Apr 2022

Antibiotic News and Research

Scientists restructure the genome of E. coli using fragments extracted from mummy

Novel insights into how some bacteria evade antibiotics

Research findings provide clues on the properties that might have made A. baumannii a successful pathogen

Researchers discover distinctive antibacterial therapy that uses visible light-activated synthetic molecular machine

Study discovers new antibiotics effective against drug-resistant tuberculosis

Research shows how current drugs impact bacterial physiology

Damaged liver treated in perfusion machine for three days and then implanted into a cancer patient

Type I interferon may activate a potent immune response against harmful viruses

Immune-boosting drugs with antibiotics may reduce the health risks of fungal infections

Scientists detect rare genetic signs of drug-resistant tuberculosis with the aim to stop disease progression

Researchers highlight a phage-antibiotic combo against antibiotic-resistant superbug

Study addresses genetic diversity of Clostridioides difficile using systems biology technique

Encapsulated peptide could provide a new approach to fighting bacterial infections

New automated system behaves as a promising tool to treat human bloodstream infections

Microcolonies in the GI tract comprise an important niche for cell-cell signaling and plasmid transfer

Research sheds light on non-invasive conjunctival goblet cell testing in patients

Rockefeller scientists reveal how a narrow-spectrum antibiotic selectively targets C. diff

Transposons are a potential antibiotic resistance, a study reveals

Researchers discover a unique technique to fight hospital-borne disease

Researchers show how proteins form DNA-repair mechanism in living bacteria

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics